Monograph
A01AD02 - Benzydamine |
Propably not porphyrinogenic |
PNP |
Rationale
Benzydamine is locally active and there is no significant systemic exposure.
Therapeutic characteristics
Anti-inflammatory NSAID used in oral rinse or mouth spray in painful inflammatory conditions of oropharynx.
Metabolism and pharmacokinetics
Irrelevant (no significant systemic exposure)
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). benzydamine hydrochlorid
|
|
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
United Kingdom
Denmark
Norway
Poland
Iceland
Finland
Latvia
Serbia© NAPOS 2024